WithdrawnNot Applicable

Treat Primary and Metastatic Liver Tumors

Stopped: Resources

0Started 2016-04-26

Plain-language summary

The use of Radiospheres in the management of intrahepatic cholangiocarcinoma is largely unknown and not reported in the medical literature. Methodist Dallas Medical Center has a large volume of IR procedures with Radioembolization and the investigators feel it is imperative to understand the outcomes, risks and benefits of the therapy in order to formulate recommendation to other centers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with the diagnosis of intrahepatic cholangiocarcinoma from January 2006 until April 2017 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older Exclusion Criteria: * Patients without the diagnosis of intrahepatic cholangiocarcinoma * Patients under 18 years of age

What they're measuring

review the outcomes of patients treated with radiospheres

Timeframe: January 2006 until April 2017

time to recurrence

Timeframe: January 2006 until April 2017

Trial details

NCT IDNCT05240040

SponsorMethodist Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More Intrahepatic Cholangiocarcinoma trials